Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Mechanism Explains Increased Insulin Resistance in Type II Diabetes

By LabMedica International staff writers
Posted on 11 Apr 2012
A recent paper outlined the molecular mechanism that makes the p75 neurotrophin receptor (p75NTR) a key regulator of glucose uptake and insulin resistance and suggested a possible new therapeutic approach for the treatment of type II diabetes.

Investigators at the University of California, San Francisco (USA) identified p75NTR as being associated with glucose regulation due to its location in fat and muscle tissue and its participation in many aspects of cell metabolism. More...
To examine more precisely the role of p75NTR they genetically engineered a line of mice to lack the gene that produces this protein.

Results published in the March 28, 2012, online edition of the journal Proceedings of the [US] National Academy of Sciences revealed that compared to normal animals, the p75NTR “knockout” mice demonstrated increased insulin sensitivity on normal chow diet, independent of changes in body weight. Deletion of the p75NTR gene increased the insulin-stimulated glucose disposal rate and suppression of hepatic glucose production.

Other mice were manipulated to overexpress p75NTR in their adipocytes. In these animals, insulin-stimulated glucose transport was decreased. In adipocytes, p75NTR was found to form a complex with the Rab5 family GTPases Rab5 and Rab31 that regulate the activity of the glucose transport protein GLUT4. Rab5 and Rab31 directly interacted with p75NTR primarily via helix 4 of the p75NTR death domain. Adipocytes from p75NTR knockout mice showed increased Rab5 and decreased Rab31 activities, and dominant negative Rab5 rescued the increase in glucose uptake seen in p75NTR knockout adipocytes.

“We identified that p75NTR is a unique player in glucose metabolism,” said senior author Dr. Katerina Akassoglou, associate professor of neurology at the University of California, San Francisco. “Therapies targeted at p75NTR may represent a new therapeutic approach for diabetes, and our studies of p75NTR's unanticipated role in regulating glucose metabolism suggest a new target for drug therapies. Future work is needed to test whether this finding may translate into a potential treatment.”

Related Links:
University of California, San Francisco




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.